Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 25.03% is 13% above its 5-year average of 22.20%, around the middle of its 5-year range (3.12%–39.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 54.72% above its 12-month average of 16.18%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.03%.
DEBT TO ASSETS RATIO
25.03%
DEBT TO ASSETS RATIO AVG TTM
16.18%
DEBT TO ASSETS RATIO AVG 3Y
19.66%
DEBT TO ASSETS RATIO AVG 5Y
22.20%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+54.72%
CURRENT VS 3Y AVG
+27.31%
CURRENT VS 5Y AVG
+12.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+22654.16%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.52B
Debt to Assets Ratio
25.03%
TTM Avg
16.18%
3Y Avg
19.66%
5Y Avg
22.20%
Market Cap
$1.45B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.43B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.52B | 25.03% | 16.18% | 19.66% | 22.20% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 0.16% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.57B | 0.21% | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 0.85% | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 0.02% | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | 0.00% | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.76% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 0.22% | N/A | N/A | N/A |
Debt/Assets
25.0%
Debt/Equity
0.62
Current Ratio
1.52
Interest Coverage
0.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 25.03% |
| 2026-03-31 | 12.54% |
| 2025-12-31 | 10.04% |
| 2025-09-30 | 3.12% |
| 2025-06-30 | 30.16% |
| 2025-03-31 | 35.89% |
| 2024-12-31 | 39.40% |
| 2024-09-30 | 12.07% |
| 2024-06-30 | 15.33% |
| 2024-03-31 | 16.58% |
| 2023-12-31 | 17.19% |
| 2023-09-30 | 18.34% |
| 2023-06-30 | 19.91% |
| 2023-03-31 | 27.30% |
| 2022-12-31 | 26.06% |
| 2022-09-30 | 29.67% |
| 2022-06-30 | 27.58% |
| 2022-03-31 | 27.63% |
| 2021-12-31 | 24.38% |
| 2021-09-30 | 25.10% |
| 2021-06-30 | 22.78% |
| 2021-03-31 | 22.95% |
| 2020-12-31 | 27.14% |
| 2020-09-30 | 61.49% |
| 2020-06-30 | 33.99% |
| 2020-03-31 | 26.51% |
| 2019-12-31 | 26.70% |
| 2019-09-30 | 0.38% |
| 2019-06-30 | 0.47% |
| 2019-03-31 | 0.52% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
